European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline ; volume:24 ; number:1 ; day:11 ; month:4 ; year:2023 ; pages:1-12 ; date:12.2023
The journal of headache and pain ; 24, Heft 1 (11.4.2023), 1-12, 12.2023
- Urheber
-
Lampl, Christian
Versijpt, Jan
Amin, Faisal Mohammad
Deligianni, Christina I.
Gil-Gouveia, Raquel
Jassal, Tanvir
MaassenVanDenBrink, Antoinette
Ornello, Raffaele
Paungarttner, Jakob
Sanchez-del-Rio, Margarita
Reuter, Uwe
Uluduz, Derya
Vries, Tessa de
Zeraatkar, Dena
Sacco, Simona
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-023-01573-6
- URN
-
urn:nbn:de:101:1-2023082309393684985920
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lampl, Christian
- Versijpt, Jan
- Amin, Faisal Mohammad
- Deligianni, Christina I.
- Gil-Gouveia, Raquel
- Jassal, Tanvir
- MaassenVanDenBrink, Antoinette
- Ornello, Raffaele
- Paungarttner, Jakob
- Sanchez-del-Rio, Margarita
- Reuter, Uwe
- Uluduz, Derya
- Vries, Tessa de
- Zeraatkar, Dena
- Sacco, Simona
- SpringerLink (Online service)
Ähnliche Objekte (12)
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
Randomized controlled trials: a critical re-appraisal
Randomized controlled trials—a critical re-appraisal
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
Debate: Are cluster headache and migraine distinct headache disorders?
Intraductal carcinoma of the prostate: a critical re-appraisal
Migraine headache and labor market outcomes
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
Randomized controlled trials: a critical re-appraisal
Randomized controlled trials—a critical re-appraisal
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
Debate: Are cluster headache and migraine distinct headache disorders?
Intraductal carcinoma of the prostate: a critical re-appraisal
Migraine headache and labor market outcomes
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
Randomized controlled trials: a critical re-appraisal
Randomized controlled trials—a critical re-appraisal
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
Debate: Are cluster headache and migraine distinct headache disorders?
Intraductal carcinoma of the prostate: a critical re-appraisal